Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities.

Kordias, Dimitris; Kostara, Christina E; Papadaki, Styliani; Verigos, John; Bairaktari, Eleni; Magklara, Angeliki

Kordias, Dimitris; Kostara, Christina E; Papadaki, Styliani; Verigos, John; Bairaktari, Eleni; Magklara, Angeliki.

Afiliación

Kordias D; Biomedical Research Institute-Foundation for Research and Technology, 45110 Ioannina, Greece.
Kostara CE; Department of Clinical Chemistry, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Papadaki S; Department of Clinical Chemistry, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Verigos J; Department of Clinical Chemistry, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.
Bairaktari E; Biomedical Research Institute-Foundation for Research and Technology, 45110 Ioannina, Greece.
Magklara A; Department of Clinical Chemistry, Faculty of Medicine, University of Ioannina, 45110 Ioannina, Greece.

Cells ; 11(17)2022 08 31.

Article en En | MEDLINE | ID: mdl-36078127

Asunto(s)

Antineoplásicos; Neoplasias de la Mama Triple Negativas; Antineoplásicos/farmacología; Línea Celular Tumoral; Resistencia a Antineoplásicos/genética; Humanos; Paclitaxel/farmacología; Paclitaxel/uso terapéutico; Neoplasias de la Mama Triple Negativas/tratamiento farmacológico; Neoplasias de la Mama Triple Negativas/genética; Neoplasias de la Mama Triple Negativas/metabolismo

Palabras clave

MSMO1; cholesterol biosynthesis; drug resistance; lipidomics; metabolomics; myo-inositol; transcriptomics; triple negative breast cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Triple Negativas / Antineoplásicos Límite: Humans Idioma: En Revista: Cells Año: 2022 Tipo del documento: Article País de afiliación: Grecia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google